<DOC>
	<DOC>NCT02504307</DOC>
	<brief_summary>Prospective, single center, randomized and non-inferiority study, to include up to 60 patients with de novo coronary artery disease. Patients will be followed at 30 days, 3, 6 and 12 months. At 3 months all patients will be submitted to angiographic and OCT evaluation.</brief_summary>
	<brief_title>OCT Evaluation 3 Months After Sirolimus Eluting Stent Implantation</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Sirolimus</mesh_term>
	<mesh_term>Everolimus</mesh_term>
	<criteria>one or two de novo lesions (&gt; 50% visual estimation) lesion diameter between 2.5 and 3.5 mm lesion length up to 33 mm. MI within the last 72 hours restenotic lesion.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>